AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11860048 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 505
Study 11860048 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional measures of nicotine dependence
Number of subjects: 505
Study 9486387 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of Hib vaccine
Number of subjects: 111
Study 9486387 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of Hib vaccine
Number of subjects: 111
Study 8106775 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-adapted reassortant influenza B/Ann Arbor/1/86 or B/Yamagata/16/88 viruses (10(7.2) TCID50)
Number of subjects: 0
Study 8106775 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral trivalent inactivated influenza vaccine containing either influenza B/Ann Arbor/86 or B/Yamagata/88 hemagglutinin antigens
Number of subjects: 0
Study 8106775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2633018 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy bupivacaine 12 mg
Number of subjects: 43
Study 2633018 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine 12 mg in 2.5 mL of 10% dextrose
Number of subjects: 43
Study 56898 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% Oxypolygelatine-solution
Number of subjects: 30
Study 56898 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5% Dextran 60 solution
Number of subjects: 30
Study 56898 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% Hydroxyethyl starch solution
Number of subjects: 30
Study 31707618 — intervention group
Group type: EXPERIMENTAL
Intervention: System B unit
Number of subjects: 45
Study 31707618 — intervention group
Group type: EXPERIMENTAL
Intervention: Elements Obturation Unit
Number of subjects: 45
Study 31707618 — intervention group
Group type: EXPERIMENTAL
Intervention: B&L SuperEndo Alpha II unit
Number of subjects: 45
Study 30644627 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaping reinforcement (indexed by vaping frequency, e-cigarette characteristics)
Number of subjects: 2896
Study 30644627 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaping enthusiasm (measured by e-cigarette modifications, using non-tobacco flavors, puffs per use)
Number of subjects: 2896
Study 30644627 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine/tobacco flavor (nicotine strength, tobacco flavors)
Number of subjects: 2896
Study 29173739 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week psychosocial intervention targeting psychosocial factors
Number of subjects: 310
Study 29173739 — intervention group
Group type: COMPARATOR
Intervention: Health promotion control
Number of subjects: 310
Study 29173739 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week psychosocial intervention
Number of subjects: 310
Study 26009916 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate placement of a provisional crown after sinus elevation bone grafting at the time of implant placement (G2)
Number of subjects: 80
Study 26009916 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate placement of a provisional crown with no bone augmentation (G3)
Number of subjects: 80
Study 26009916 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed restoration after sinus elevation bone grafting followed by a 6-month healing period (G4)
Number of subjects: 80
Study 26009916 — intervention group
Group type: COMPARATOR
Intervention: G2 vs G3
Number of subjects: 80
Study 26009916 — intervention group
Group type: COMPARATOR
Intervention: G2 vs G4
Number of subjects: 80
Study 26009916 — intervention group
Group type: COMPARATOR
Intervention: G3 vs G4
Number of subjects: 80
Study 23208767 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (HS)
Number of subjects: 59
Study 23208767 — intervention group
Group type: COMPARATOR
Intervention: Conventional hand‐tied ligation (CT)
Number of subjects: 59
Study 21615360 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection of the ilioinguinal nerve
Number of subjects: 19
Study 21615360 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 19
Study 21615360 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection after medical treatment
Number of subjects: 19
Study 19651921 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (perindopril-indapamide + intensive glucose control)
Number of subjects: 11140
Study 16337687 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning light treatment for 8 weeks
Number of subjects: 43
Study 16337687 — intervention group
Group type: COMPARATOR
Intervention: Baseline SIGH‐SAD ratings
Number of subjects: 43
Study 16337687 — intervention group
Group type: COMPARATOR
Intervention: Posttreatment SIGH‐SAD ratings
Number of subjects: 43
Study 16337687 — intervention group
Group type: EXPERIMENTAL
Intervention: T(min) estimated pre- and posttreatment
Number of subjects: 43
Study 16337687 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase of sleep-wake rhythm assessed by daily sleep logs
Number of subjects: 43
Study 15349005 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine extended-release (VXR)
Number of subjects: 2045
Study 15349005 — intervention group
Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 2045
Study 12807696 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma nurse specialist intervention (n = 50)
Number of subjects: 96
Study 12807696 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (n = 46)
Number of subjects: 96
Study 9658370 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha)
Number of subjects: 100
Study 8519507 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 0
Study 8519507 — intervention group
Group type: COMPARATOR
Intervention: Current recommendations for breast cancer screening (mammography, clinical breast examination, breast self-examination)
Number of subjects: 0
Study 8519507 — intervention group
Group type: EXPERIMENTAL
Intervention: Future randomized trial of mammography in women younger than 50 years
Number of subjects: 0
Study 2212961 — intervention group
Group type: EXPERIMENTAL
Intervention: ESAT 6660 glucose analyser
Number of subjects: 21
Study 115049 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 320 microgram/kg
Number of subjects: 15
Study 115049 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.54 g/kg
Number of subjects: 15
Study 115049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31734442 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 94
Study 31734442 — intervention group
Group type: COMPARATOR
Intervention: Sham transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 94
Study 28129069 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk information presented at the bottom of the homepage
Number of subjects: 5246
Study 28129069 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk information presented at the bottom of the homepage with a signal above indicating that the risk information was located below
Number of subjects: 5246
Study 28129069 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk information presented on a linked secondary page
Number of subjects: 5246
Study 28129069 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk information format varied (paragraph, checklist, bulleted list, highlighted box)
Number of subjects: 5246
Study 25587056 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive optics microperimetry (AOMP) at normal-appearing cones (N) sites
Number of subjects: 3
Study 25587056 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive optics microperimetry (AOMP) at dimly reflecting cones (D) sites
Number of subjects: 3
Study 25587056 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive optics microperimetry (AOMP) at RPE cell mosaics (R) sites
Number of subjects: 3
Study 25587056 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall lesion surface area
Number of subjects: 3
Study 25587056 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual sensitivity assessment
Number of subjects: 3
Study 23827726 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD1981 1000 mg twice daily
Number of subjects: 118
Study 23827726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 21691611 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium oxide-anodized (ADZ) implants
Number of subjects: 10
Study 21691611 — intervention group
Group type: COMPARATOR
Intervention: Machined implants
Number of subjects: 10
Study 19782872 — intervention group
Group type: EXPERIMENTAL
Intervention: Drain inserted into the subdural space
Number of subjects: 269
Study 19782872 — intervention group
Group type: COMPARATOR
Intervention: No drain
Number of subjects: 269
Study 16905387 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen-detected invasive cancers
Number of subjects: 232
Study 16905387 — intervention group
Group type: COMPARATOR
Intervention: Previous mammograms of women with screen-detected cancer
Number of subjects: 232
Study 15526717 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum leptin levels in girls with premature pubarche (PP)
Number of subjects: 39
Study 15526717 — intervention group
Group type: COMPARATOR
Intervention: Serum leptin levels in prepubertal controls (C)
Number of subjects: 39
Study 15526717 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum DHEAS levels in girls with premature pubarche (PP)
Number of subjects: 39
Study 15526717 — intervention group
Group type: COMPARATOR
Intervention: Serum DHEAS levels in prepubertal controls (C)
Number of subjects: 39
Study 15526717 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum androstenedione (A) levels in girls with premature pubarche (PP)
Number of subjects: 39
Study 15526717 — intervention group
Group type: COMPARATOR
Intervention: Serum androstenedione (A) levels in prepubertal controls (C)
Number of subjects: 39
Study 15526717 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum insulin (I) levels in girls with obesity (OB)
Number of subjects: 39
Study 15526717 — intervention group
Group type: COMPARATOR
Intervention: Serum insulin (I) levels in non-obese (nOB) girls
Number of subjects: 39
Study 15526717 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting glucose (G) levels in girls with obesity (OB)
Number of subjects: 39
Study 15526717 — intervention group
Group type: COMPARATOR
Intervention: Fasting glucose (G) levels in non-obese (nOB) girls
Number of subjects: 39
Study 15526717 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol (TC) levels in girls with obesity (OB)
Number of subjects: 39
Study 15526717 — intervention group
Group type: COMPARATOR
Intervention: Total cholesterol (TC) levels in non-obese (nOB) girls
Number of subjects: 39
Study 15526717 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin resistance (IR) observed in girls with obesity (OB)
Number of subjects: 39
Study 15526717 — intervention group
Group type: COMPARATOR
Intervention: Insulin resistance (IR) observed in non-obese (nOB) girls
Number of subjects: 39
Study 11251136 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mL of 0.25% bupivacaine
Number of subjects: 100
Study 11251136 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study 9210503 — intervention group
Group type: EXPERIMENTAL
Intervention: BT563 (10 mg/day; days 0-12; n=39)
Number of subjects: 80
Study 9210503 — intervention group
Group type: COMPARATOR
Intervention: ATG (5 mg/kg/day; days 0-6; n=41)
Number of subjects: 80
Study 7962884 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapse Prevention (RP) program
Number of subjects: 18
Study 7962884 — intervention group
Group type: COMPARATOR
Intervention: Associative Therapy (AT; attention-control program)
Number of subjects: 18
Study 29533726 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion with menthol (CMWI)
Number of subjects: 8
Study 29533726 — intervention group
Group type: COMPARATOR
Intervention: Cold water immersion without menthol (CWI)
Number of subjects: 8
Study 26420062 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care (n = 47)
Number of subjects: 95
Study 26420062 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (n = 48)
Number of subjects: 95
Study 25229735 — intervention group
Group type: EXPERIMENTAL
Intervention: FES-assisted walking therapy
Number of subjects: 0
Study 25229735 — intervention group
Group type: COMPARATOR
Intervention: Aerobic and resistance training program (control)
Number of subjects: 0
Study 25229735 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (FES and control)
Number of subjects: 0
Study 22739979 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive nurse practitioner support
Number of subjects: 788
Study 22739979 — intervention group
Group type: COMPARATOR
Intervention: Nephrologist care (Control)
Number of subjects: 788
Study 19642883 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (200 mg)
Number of subjects: 40
Study 19642883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 18470300 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention to reduce pesticide exposure
Number of subjects: 0
Study 18470300 — intervention group
Group type: COMPARATOR
Intervention: Control community
Number of subjects: 0
Study 15719189 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled anastomosis
Number of subjects: 37
Study 15719189 — intervention group
Group type: COMPARATOR
Intervention: Handsewn anastomosis
Number of subjects: 37
Study 15719189 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 37
Study 12845933 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n = 9) performing a progressive cardiovascular graded exercise protocol and resistance training twice a week for 12 weeks
Number of subjects: 17
Study 12845933 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group (n = 8)
Number of subjects: 17
Study 10949062 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant growth hormone (rhGH) administered at doses 10-20 times higher than those used for replacement therapy
Number of subjects: 0
Study 10949062 — intervention group
Group type: COMPARATOR
Intervention: Standard parenteral or enteral nutritional formulas
Number of subjects: 0
Study 9265606 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity programmes for caregivers and changed ward policies to encourage caregiver participation in study wards.
Number of subjects: 97
Study 9265606 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality assurance programmes and primary nursing introduced in study wards.
Number of subjects: 97
Study 9265606 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 97
Study 1412678 — intervention group
Group type: EXPERIMENTAL
Intervention: 37°C incubated apheresis platelets
Number of subjects: 14
Study 1412678 — intervention group
Group type: COMPARATOR
Intervention: Paired control platelets
Number of subjects: 14
Study 6483639 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 650 mg
Number of subjects: 148
Study 6483639 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenyltoloxamine 60 mg
Number of subjects: 148
Study 6483639 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of acetaminophen 650 mg and phenyltoloxamine 60 mg
Number of subjects: 148
Study 6483639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 31364490 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily
Number of subjects: 15526
Study 31364490 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 5 mg twice daily
Number of subjects: 15526
Study 31364490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15526
Study 29947090 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidneys from donors dying after ligature asphyxiation (both DBD and DCD)
Number of subjects: 409
Study 26471409 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn Soya Blend Plus (CSBP)
Number of subjects: 288
Study 24276303 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised, periodized exercise training with a personal trainer (TRAINED)
Number of subjects: 34
Study 24276303 — intervention group
Group type: COMPARATOR
Intervention: Self-directed training (SELF)
Number of subjects: 34
Study 21570204 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous 7‐days‐a‐week pelvic irradiation (1.6 Gy daily for Group A, 1.8 Gy daily for Group B)
Number of subjects: 30
Study 21570204 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous 7‐days‐a‐week pelvic irradiation
Number of subjects: 30
Study 19617657 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-lipoic acid, 600 mg . day(‐1), for 8 days
Number of subjects: 33
Study 19617657 — intervention group
Group type: COMPARATOR
Intervention: Control group (T(CON))
Number of subjects: 33
Study 17426529 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 0
Study 17426529 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR generic
Number of subjects: 0
Study 17426529 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR brand
Number of subjects: 0
Study 17426529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16320557 — intervention group
Group type: EXPERIMENTAL
Intervention: Microlaparoscopy under sedation
Number of subjects: 54
Study 16320557 — intervention group
Group type: EXPERIMENTAL
Intervention: Microlaparoscopy under general anesthesia
Number of subjects: 54
Study 16320557 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopy
Number of subjects: 54
Study 12470353 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer of a single zona-free blastocyst on day 5
Number of subjects: 420
Study 12470353 — intervention group
Group type: COMPARATOR
Intervention: Transfer of a single zona-intact embryo
Number of subjects: 420
Study 9432078 — intervention group
Group type: EXPERIMENTAL
Intervention: Sniffin' Sticks olfactory test
Number of subjects: 63
Study 9432078 — intervention group
Group type: EXPERIMENTAL
Intervention: Dirhinic testing
Number of subjects: 63
Study 9432078 — intervention group
Group type: COMPARATOR
Intervention: Monorhinic testing
Number of subjects: 63
Study 8082553 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine 150 mg daily
Number of subjects: 94
Study 8082553 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine 300 mg daily
Number of subjects: 94
Study 8082553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 2815804 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermic perfusion with Melphalan (42 degrees C)
Number of subjects: 107
Study 2815804 — intervention group
Group type: COMPARATOR
Intervention: Control group (wide excision and lymph node dissection)
Number of subjects: 107
Study 807698 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 36
Study 807698 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (4,000 IU daily for two months)
Number of subjects: 36
Study 807698 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D (single large oral dose)
Number of subjects: 36
Study 31132795 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 3005
Study 31132795 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 3005
Study 31132795 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 50 mg
Number of subjects: 3005
Study 31132795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3005
Study 31132795 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events (CNS-related)
Number of subjects: 3005
Study 27389174 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofatumumab 500 mg plus fludarabine and cyclophosphamide (FC)
Number of subjects: 0
Study 27389174 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofatumumab 1000 mg plus fludarabine and cyclophosphamide (FC)
Number of subjects: 0
Study 27389174 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofatumumab pharmacokinetics
Number of subjects: 0
Study 27389174 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline patient/disease factors
Number of subjects: 0
Study 25800753 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate plus prednisone
Number of subjects: 711
Study 25800753 — intervention group
Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 711
Study 23691002 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective transurethral resection of the prostate (STURP) combined with transurethral incision of the bladder neck (TUIBN)
Number of subjects: 124
Study 23691002 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 124
Study 22221440 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose montelukast (4 or 5 mg)
Number of subjects: 66
Study 22221440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 19575797 — intervention group
Group type: EXPERIMENTAL
Intervention: artemisinin/naphtoquine (AN)
Number of subjects: 122
Study 19575797 — intervention group
Group type: COMPARATOR
Intervention: artemether/lumefantrine (AL)
Number of subjects: 122
Study 17301298 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic treatment (including lithotripsy)
Number of subjects: 39
Study 17301298 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical drainage (operative pancreaticojejunostomy)
Number of subjects: 39
Study 15166532 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV
Number of subjects: 692
Study 15166532 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-HBV
Number of subjects: 692
Study 15166532 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-HCV
Number of subjects: 692
Study 11479154 — intervention group
Group type: EXPERIMENTAL
Intervention: CRF patients
Number of subjects: 3
Study 11479154 — intervention group
Group type: EXPERIMENTAL
Intervention: ESRD-HD patients
Number of subjects: 3
Study 11479154 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (CON)
Number of subjects: 3
Study 11479154 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMCs of ESRD-HD patients after IL-4 and IL-10 neutralization
Number of subjects: 3
Study 9744445 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (n = 20, 2 minutes waiting time between FDEs)
Number of subjects: 30
Study 9744445 — intervention group
Group type: COMPARATOR
Intervention: Group B (n = 10, 10 minutes waiting time between FDEs)
Number of subjects: 30